[Hereditary angioneurotic edema in gynecology-obstetrics. Management]. 1996

H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
Clinique Universitaire de Gynécologie, d'Obstétrique et de la Reproduction, CHRU, Besançon.

Hereditary angioneurotic edema is a rare disease (250 cases currently identified in France). It is the most frequent among hereditary deficiencies of the complement system. This severe disease is fatal in 15-20% of the patients before 40 years of age. Death can be prevented if correct steps are taken in case of even minor trauma, which often trigger acute, potentially fatal, episodes. Danazol is used as preventive therapy before surgery and C1-esterase inhibitor or fresh frozen plasma is given for acute episodes. In case of obstetrical trauma, C1-esterase inhibitors should be used either as prophylaxy or as treatment. Fresh frozen plasma is used if C1-esterase inhibitors are not available. We report here our experience with three patients with known hereditary angioneurotic edema. Gynecology surgery was required in two.

UI MeSH Term Description Entries
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D003174 Complement C1 Inactivator Proteins Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits. Complement 1 Esterase Inhibitors,Complement C1 Inactivating Proteins,Complement C1 Inhibiting Proteins,Complement C1 Inhibitor Proteins,Complement C1r Protease Inhibitor Proteins,Complement C1s Esterase Inhibitor Proteins,Complement Component 1 Inactivator Proteins
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000799 Angioedema Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx. Quincke's Edema,Urticaria, Giant,Angioneurotic Edema,Angioedemas,Angioneurotic Edemas,Edema, Angioneurotic,Edema, Quincke's,Edemas, Angioneurotic,Giant Urticaria,Giant Urticarias,Quincke Edema,Quinckes Edema,Urticarias, Giant

Related Publications

H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
January 1990, Chirurgie pediatrique,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
November 1981, Orvosi hetilap,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
January 1968, Revista clinica espanola,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
June 1974, Lakartidningen,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
September 1974, Zeitschrift fur Hautkrankheiten,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
November 1979, Disease-a-month : DM,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
February 1999, Indian pediatrics,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
January 1982, Nihon rinsho. Japanese journal of clinical medicine,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
August 1975, Dermatologische Monatschrift,
H Khalife, and D Riethmuller, and P Roth, and P Koeberle, and J P Schaal, and R Maillet
November 1976, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!